Evaluating the effectiveness and utility of a novel culturally

Evaluating the effectiveness and utility of a novel culturally-adapted telemonitoring system in bettering the glycaemic management of Asians with type-2 diabetes mellitus: a blended technique research protocol

Background: Common supervision of sufferers with type-2 diabetes mellitus (T2DM) by healthcare suppliers is crucial to optimise their glycaemic management however is difficult to attain in present care fashions. Telemonitoring is postulated to bridge this hole by leveraging on internet-of-things and mobile-health expertise. This research goals to find out the effectiveness of a novel telemonitoring system (OPTIMUM) in bettering the glycaemic management of sufferers with T2DM in contrast with commonplace of care alone.

Strategies: This mixed-method research contains an preliminary randomised managed trial involving 330 Asian adults with T2DM, aged 26-65 years outdated with an HbA1c of seven.5-10%, with 115 within the intervention and management arms every. These within the intervention arm will use standardised Bluetooth-enabled gadgets to transmit their capillary glucose, blood strain and weight measurements to the OPTIMUM system.

Main care physicians and nurses will remotely supervise them in accordance with an embedded administration algorithm for six months, together with tele-education by way of weekly movies over Eight weeks and asynchronous tele-consultation if irregular or absent parameters are detected. Sufferers in each arms will probably be assessed at baseline, 6, 12 and 24 months post-recruitment.

The first end result will probably be their HbA1c distinction between each arms at baseline and 6 months. Blood strain and weight management; high quality of life, medicine adherence, confidence in self-management, diabetic literacy and associated misery and healthcare utilisation utilizing validated questionnaires; and incident retinal, renal, cardiac and cerebrovascular problems will probably be in contrast between the 2 arms as secondary outcomes at stipulated time-points. Intervention arm sufferers will probably be interviewed utilizing qualitative analysis strategies to grasp their expertise, acceptance and perceived usefulness of the OPTIMUM system.

Dialogue: General, this research seeks to judge the effectiveness of cultural-adapted telemonitoring system in bettering glycaemic management of Asians with type-2 diabetes mellitus in comparison with commonplace of care. The outcomes of this trial will higher inform coverage makers in adopting telemedicine for inhabitants well being administration.

insuline-medical
insuline-medical

RRAD antibody

70R-5798 50 ug
EUR 560.4
Description: Rabbit polyclonal RRAD antibody raised against the middle region of RRAD

RRAD Antibody

37229-100ul 100ul
EUR 302.4

RRAD Antibody

CSB-PA233809- each
EUR 402
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500

RRAD Antibody

CSB-PA233809-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:3000, IHC:1:50-1:100, IF:1:100-1:500

RRAD Antibody

1-CSB-PA248209
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100

RRAD Antibody

1-CSB-PA003910
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/20000

RRAD Antibody

1-CSB-PA779820
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAD. Recognizes RRAD from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

RRAD Antibody

R34275-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Ras-related associated with diabetes

Polyclonal RRAD Antibody

APR05556G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAD . This antibody is tested and proven to work in the following applications:

RRAD Conjugated Antibody

C37229 100ul
EUR 476.4

GTP-binding protein RAD (RRAD) Antibody

20-abx214509
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

GTP-binding protein RAD (RRAD) Antibody

20-abx324872
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

GTP-binding protein RAD (RRAD) Antibody

20-abx241706
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

GTP-Binding Protein RAD (RRAD) Antibody

20-abx008742
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

GTP-Binding Protein RAD (RRAD) Antibody

abx432011-200ul 200 ul
EUR 460.8

GTP-binding protein RAD (RRAD) Antibody

abx332370-100ul 100 ul
EUR 510

Rrad/ Rat Rrad ELISA Kit

ELI-14921r 96 Tests
EUR 1063.2

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx237237-100ug 100 ug
EUR 661.2

RRAD And GEM Like GTPase 2 (REM2) Antibody

abx122938-100ug 100 ug
EUR 469.2

RRAD siRNA

20-abx932133
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

Polyclonal RRAD (aa36-48) Antibody (internal region)

APG00807G 0.1mg
EUR 580.8
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human RRAD (aa36-48) (internal region). This antibody is tested and proven to work in the following applications:

RRAD Peptide

43-008P 0.1 mg
EUR 405.6
Description: RRAD Peptide

RRAD Blocking Peptide

20-abx063234
  • EUR 326.40
  • EUR 493.20
  • 1 mg
  • 5 mg

RRAD Blocking Peptide

33R-10070 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5798

RRAD Blocking Peptide

33R-4793 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RRAD antibody, catalog no. 70R-5797

RRAD ELISA KIT|Human

EF005507 96 Tests
EUR 826.8

Human RRAD shRNA Plasmid

20-abx954199
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

RRAD Recombinant Protein (Rat)

RP226925 100 ug Ask for price

RRAD Recombinant Protein (Mouse)

RP169340 100 ug Ask for price

RRAD Recombinant Protein (Human)

RP095493 100 ug Ask for price

Rrad ORF Vector (Rat) (pORF)

ORF075643 1.0 ug DNA
EUR 607.2

RRAD ORF Vector (Human) (pORF)

ORF031832 1.0 ug DNA
EUR 486

Rrad ORF Vector (Mouse) (pORF)

ORF056448 1.0 ug DNA
EUR 607.2

Rrad sgRNA CRISPR Lentivector set (Rat)

K7052701 3 x 1.0 ug
EUR 406.8

RRAD 3'UTR GFP Stable Cell Line

TU072380 1.0 ml
EUR 1672.8

Rrad 3'UTR GFP Stable Cell Line

TU269725 1.0 ml Ask for price

Rrad 3'UTR GFP Stable Cell Line

TU168183 1.0 ml Ask for price

Rrad sgRNA CRISPR Lentivector set (Mouse)

K3480701 3 x 1.0 ug
EUR 406.8

RRAD sgRNA CRISPR Lentivector set (Human)

K2069901 3 x 1.0 ug
EUR 406.8

RRAD Protein Vector (Rat) (pPM-C-HA)

PV302572 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPB-C-His)

PV302570 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPB-N-His)

PV302571 500 ng
EUR 723.6

RRAD Protein Vector (Rat) (pPM-C-His)

PV302573 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPM-C-HA)

PV225792 500 ng
EUR 723.6

RRAD Protein Vector (Human) (pPM-C-HA)

PV127328 500 ng
EUR 662.4

RRAD Protein Vector (Mouse) (pPB-C-His)

PV225790 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPB-N-His)

PV225791 500 ng
EUR 723.6

RRAD Protein Vector (Mouse) (pPM-C-His)

PV225793 500 ng
EUR 723.6

RRAD Protein Vector (Human) (pPB-C-His)

PV127326 500 ng
EUR 662.4

RRAD Protein Vector (Human) (pPB-N-His)

PV127327 500 ng
EUR 662.4

RRAD Protein Vector (Human) (pPM-C-His)

PV127329 500 ng
EUR 662.4

RRAD 3'UTR Luciferase Stable Cell Line

TU022380 1.0 ml
EUR 1672.8

Rrad 3'UTR Luciferase Stable Cell Line

TU118183 1.0 ml Ask for price

Rrad 3'UTR Luciferase Stable Cell Line

TU219725 1.0 ml Ask for price

Rrad sgRNA CRISPR Lentivector (Rat) (Target 1)

K7052702 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Rat) (Target 2)

K7052703 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Rat) (Target 3)

K7052704 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3480702 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3480703 1.0 ug DNA
EUR 184.8

Rrad sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3480704 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 1)

K2069902 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 2)

K2069903 1.0 ug DNA
EUR 184.8

RRAD sgRNA CRISPR Lentivector (Human) (Target 3)

K2069904 1.0 ug DNA
EUR 184.8

Rat GTP-binding protein RAD (RRAD) ELISA Kit

abx391893-96tests 96 tests
EUR 1093.2

Human GTP- binding protein RAD, RRAD ELISA KIT

ELI-35549h 96 Tests
EUR 988.8

Mouse GTP- binding protein RAD, Rrad ELISA KIT

ELI-14089m 96 Tests
EUR 1038

Human GTP-binding protein RAD (RRAD) ELISA Kit

abx385354-96tests 96 tests
EUR 1093.2

Mouse GTP-binding protein RAD (RRAD) ELISA Kit

abx390415-96tests 96 tests
EUR 1093.2

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV658369 1.0 ug DNA
EUR 616.8

RRAD Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV658373 1.0 ug DNA
EUR 616.8

RRAD Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV658374 1.0 ug DNA
EUR 616.8

Human RRAD And GEM Like GTPase 2 (REM2) ELISA Kit

abx382769-96tests 96 tests
EUR 1093.2

Anti-RRAD (aa36-48) antibody

STJ72757 100 µg
EUR 430.8

Rrad ELISA Kit| Rat GTP-binding protein RAD ELISA Kit

EF019253 96 Tests
EUR 826.8

Rrad ELISA Kit| Mouse GTP-binding protein RAD ELISA Kit

EF016057 96 Tests
EUR 826.8

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K7052705 3 x 1.0 ug
EUR 451.2

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3480705 3 x 1.0 ug
EUR 451.2

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K2069905 3 x 1.0 ug
EUR 451.2

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K7052706 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K7052707 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K7052708 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3480706 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3480707 1.0 ug DNA
EUR 200.4

Rrad sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3480708 1.0 ug DNA
EUR 200.4

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K2069906 1.0 ug DNA
EUR 200.4

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K2069907 1.0 ug DNA
EUR 200.4

RRAD sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K2069908 1.0 ug DNA
EUR 200.4

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV658370 1.0 ug DNA
EUR 616.8

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV658371 1.0 ug DNA
EUR 686.4

RRAD Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV658372 1.0 ug DNA
EUR 686.4

RRAGA / RRAGB Antibody

20-abx328592
  • EUR 376.80
  • EUR 292.80
  • 100 ug
  • 50 ug

RRAGA / RRAGB Antibody

abx332724-100ul 100 ul
EUR 510

RRAGA/RRAGB Antibody

CSB-PA590465- each
EUR 402
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

RRAGA/RRAGB Antibody

CSB-PA590465-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000

RRAGA/RRAGB Antibody

1-CSB-PA003930
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against RRAGA/RRAGB. Recognizes RRAGA/RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/20000

RRAS antibody

70R-20022 50 ul
EUR 522
Description: Rabbit polyclonal RRAS antibody

RRAS Antibody

37881-100ul 100ul
EUR 302.4

RRAS Antibody

1-CSB-PA663638
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100

RRAS Antibody

1-CSB-PA020513GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

RRAS Antibody

1-CSB-PA444135
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAS. Recognizes RRAS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

RRAGD Antibody

46175-100ul 100ul
EUR 302.4

RRAGD Antibody

46175-50ul 50ul
EUR 224.4

RRAGB antibody

70R-20021 50 ul
EUR 522
Description: Rabbit polyclonal RRAGB antibody

RRAS2 antibody

70R-20023 50 ul
EUR 522
Description: Rabbit polyclonal RRAS2 antibody

RRAGA antibody

70R-15303 100 ug
EUR 392.4
Description: Rabbit polyclonal RRAGA antibody

RRAGC antibody

10R-1679 100 ug
EUR 614.4
Description: Mouse monoclonal RRAGC antibody

RRAGD antibody

70R-3629 50 ug
EUR 560.4
Description: Rabbit polyclonal RRAGD antibody raised against the middle region of RRAGD

RRAGC antibody

70R-3630 50 ug
EUR 560.4
Description: Rabbit polyclonal RRAGC antibody raised against the N terminal of RRAGC

RRAS2 Antibody

7249-002mg 0.02 mg
EUR 206.18
Description: RRAS2 Antibody: Activating mutations and overexpression of classical Ras subfamily members (K-RAS, N-RAS and H-RAS) have been widely investigated as key events in the development of human cancers. The RRAS subfamily of Ras-related proteins includes RRAS1, RRAS2 (TC21) and RRAS3 (M-Ras) show overall amino acid identity with the classical Ras subfamily (H-Ras, K-Ras and N-Ras) of 55–60%. RRAS2 is a small GTPbinding protein of the Ras superfamily of GTPases. It might transduce growth inhibitory signals across the cell membrane, exerting its effect through an effector shared with the Ras proteins. RRAS2 has high oncogenic potential and overexpression/mutations have been reported in several tumor tissues and cell lines.

RRAS2 Antibody

7249-01mg 0.1 mg
EUR 523.7
Description: RRAS2 Antibody: Activating mutations and overexpression of classical Ras subfamily members (K-RAS, N-RAS and H-RAS) have been widely investigated as key events in the development of human cancers. The RRAS subfamily of Ras-related proteins includes RRAS1, RRAS2 (TC21) and RRAS3 (M-Ras) show overall amino acid identity with the classical Ras subfamily (H-Ras, K-Ras and N-Ras) of 55–60%. RRAS2 is a small GTPbinding protein of the Ras superfamily of GTPases. It might transduce growth inhibitory signals across the cell membrane, exerting its effect through an effector shared with the Ras proteins. RRAS2 has high oncogenic potential and overexpression/mutations have been reported in several tumor tissues and cell lines.

RRAS2 antibody

70R-50868 100 ul
EUR 292.8
Description: Purified Polyclonal RRAS2 antibody

RRAGD Antibody

ABD9812 100 ug
EUR 525.6

RRAS2 Antibody

ABD9840 100 ug
EUR 525.6

RRAGA Antibody

ABD7957 100 ug
EUR 525.6

RRAGC Antibody

ABD13245 100 ug
EUR 525.6

RRAGB Antibody

ABD4393 100 ug
EUR 525.6

RRAGC Antibody

ABD4394 100 ug
EUR 525.6

RRAGA Antibody

40326-100ul 100ul
EUR 302.4

RRAGC Antibody

40327-100ul 100ul
EUR 302.4

RRAS2 Antibody

40328-100ul 100ul
EUR 302.4

RRAGC Antibody

1-CSB-PA867190ESR1HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAGC. Recognizes RRAGC from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

RRAGC Antibody

1-CSB-PA931417
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAGC. Recognizes RRAGC from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100

RRAGD Antibody

DF9812 200ul
EUR 420

RRAS2 Antibody

DF9840 200ul
EUR 420

RRAGA Antibody

DF7957 200ul
EUR 420

RRAGB Antibody

DF4393 200ul
EUR 420

RRAGC Antibody

DF4394 200ul
EUR 420

RRAGA Antibody

1-CSB-PA03465A0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against RRAGA. Recognizes RRAGA from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:50-1:200, IF:1:50-1:500

RRAGC Antibody

1-CSB-PA038367
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAGC. Recognizes RRAGC from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000

RRAGC Antibody

1-CSB-PA003932
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against RRAGC. Recognizes RRAGC from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

RRAGB Antibody

1-CSB-PA006486
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against RRAGB. Recognizes RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000

RRAGB Antibody

1-CSB-PA020510GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against RRAGB. Recognizes RRAGB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

RRAS2 Antibody

1-CSB-PA020514ESR2HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAS2. Recognizes RRAS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

RRAS2 Antibody

1-CSB-PA020514GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against RRAS2. Recognizes RRAS2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

RRAGA Antibody

1-CSB-PA022239
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAGA. Recognizes RRAGA from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100

RRAGA Antibody

1-CSB-PA071515
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAGA. Recognizes RRAGA from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

RRAS2 Antibody

1-CSB-PA350769
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against RRAS2. Recognizes RRAS2 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000

RRAGD Antibody

F54410-0.08ML 0.08 ml
EUR 140.25
Description: Ras-related GTP-binding protein D is a monomeric guanine nucleotide-binding protein, or G protein. By binding GTP or GDP, small G proteins act as molecular switches in numerous cell processes and signaling pathways.

RRAGD Antibody

F54410-0.4ML 0.4 ml
EUR 322.15
Description: Ras-related GTP-binding protein D is a monomeric guanine nucleotide-binding protein, or G protein. By binding GTP or GDP, small G proteins act as molecular switches in numerous cell processes and signaling pathways.

R-Ras Antibody

DF10319 200ul
EUR 420

anti- RRAS antibody

FNab07489 100µg
EUR 658.5
Description: Antibody raised against RRAS

RRAGA/B Antibody

ABD4392 100 ug
EUR 525.6

R-Ras2 Antibody

abx140418-01mg 0.1 mg
EUR 510

RRAGA/B Antibody

34965-100ul 100ul
EUR 302.4

RRAGA/B Antibody

34965-50ul 50ul
EUR 224.4

RRAGA / B Antibody

20-abx014789
  • EUR 376.80
  • EUR 117.60
  • EUR 477.60
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

RRAGA/B Antibody

DF4392 200ul
EUR 420

anti- RRAGB antibody

FNab07488 100µg
EUR 658.5
Description: Antibody raised against RRAGB

anti- RRAS2 antibody

FNab07490 100µg
EUR 658.5
Description: Antibody raised against RRAS2

RRAGA antibody (HRP)

60R-1741 100 ug
EUR 392.4
Description: Rabbit polyclonal RRAGA antibody (HRP)

RRAGA antibody (FITC)

60R-1742 100 ug
EUR 392.4
Description: Rabbit polyclonal RRAGA antibody (FITC)

R-Ras2 Antibody (PE)

abx140419-01mg 0.1 mg
EUR 777.6

Human RRAS2 Antibody

32052-05111 150 ug
EUR 313.2

R-Ras (pY66) Antibody

abx218392-100ug 100 ug
EUR 526.8

RRAGA antibody (biotin)

60R-1743 100 ug
EUR 392.4
Description: Rabbit polyclonal RRAGA antibody (biotin)

IL- 13Ralpha1 Antibody

ABF9095 100 ug
EUR 525.6

Ras-related protein R-Ras (RRAS) Antibody

20-abx214133
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Ras-Related Protein R-Ras (RRAS) Antibody

abx237489-100ug 100 ug
EUR 610.8

Ras-Related Protein R-Ras (RRAS) Antibody

20-abx123552
  • EUR 594.00
  • EUR 427.20
  • 100 ul
  • 50 ul

Ras-related protein R-Ras (RRAS) Antibody

20-abx241995
  • EUR 493.20
  • EUR 360.00
  • 100 ul
  • 50 ul

Ras-Related Protein R-Ras (RRAS) Antibody

abx026316-400ul 400 ul
EUR 627.6

Ras-Related Protein R-Ras (RRAS) Antibody

abx026316-80l 80 µl
EUR 343.2

RRAS Polyclonal Antibody

ABP60258-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of RRAS from Human, Mouse, Rat. This RRAS antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAS protein at amino acid sequence of 1-80

RRAS Polyclonal Antibody

ABP60258-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of RRAS from Human, Mouse, Rat. This RRAS antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAS protein at amino acid sequence of 1-80

RRAS Polyclonal Antibody

ABP60258-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of RRAS from Human, Mouse, Rat. This RRAS antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human RRAS protein at amino acid sequence of 1-80

RRAS Conjugated Antibody

C37881 100ul
EUR 476.4

RRAS Polyclonal Antibody

ES9011-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against RRAS from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

RRAS Polyclonal Antibody

ES9011-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against RRAS from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

RRAGA Polyclonal Antibody

A51649
  • EUR 684.66
  • Ask for price
  • Ask for price
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

RRAGA Polyclonal Antibody

A70742
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

Polyclonal RRAS2 Antibody

APR05586G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAS2 . This antibody is tested and proven to work in the following applications:

Polyclonal RRAS2 Antibody

APR06809G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human RRAS2 . This antibody is tested and proven to work in the following applications:

[Prevalence and incidence of type 2 diabetes in Iceland 2005-2018]

Introduction: The variety of folks with kind 2 diabetes has elevated in Iceland in the previous couple of a long time. We utilized the nationwide database on prescribed medicine from the Directorate of Well being to estimate the prevalence and incidence of kind 2 diabetes in Iceland and made prediction on the prevalence of kind 2 diabetes in Iceland in 10 and 20 years.

Materials and strategies: Prevalence and incidence of kind 2 diabetes for the interval 2005-2018 was estimated primarily based on prescriptions of diabetes medicine within the nationwide prescription database containing all prescriptions in Iceland through the interval. The consequence was in comparison with the consequence from the REFINE-Reykjavik research (potential, population-based cohort research) from 2004 to 2011 and printed knowledge from the USA from 1980 to 2016.

Outcomes: The prevalence of kind 2 diabetes greater than doubled in close to all age teams in each women and men within the interval 2005-2018. The incidence elevated by 2.8% yearly (in 18-79 years outdated). The variety of folks in Iceland with kind 2 diabetes was 10600 in 2018 and had increased from 4200 within the 12 months 2005. Comparability with the outcomes of the REFINE-Reykjavik research confirmed an underestimation (29% in women and men) of the prevalence of kind 2 diabetes. If the rise in kind 2 diabetes continues at an analogous fee as within the years 2005-2018 the variety of folks with diabetes in Iceland might be close to 24000 within the 12 months 2040.

Conclusion: Linear improve was seen in incidence and prevalence of individuals with kind 2 diabetes within the years 2005-2018. Related evolution was seen in USA from 1984. To be able to counteract the rise of kind 2 diabetes following the identical path as has been seen within the USA, focused measures are wanted.

The Impact of Monetary Incentives on High quality Measures within the Remedy of Diabetes Mellitus: a Randomized Managed Trial

Background: Monetary incentives are sometimes used to enhance high quality of care in continual care sufferers. Nonetheless, the proof in regards to the impact of monetary incentives continues to be inconclusive.

Goal: To check the impact of monetary incentives on high quality measures (QMs) within the remedy of sufferers with diabetes mellitus in main care. We incentivized a scientific QM and a course of QM to check the impact of monetary incentives on various kinds of QMs and to research the spill-over impact on non-incentivized QMs.

Design/members: Parallel cluster randomized managed trial primarily based on digital medical data database involving Swiss normal practitioners (GPs). Practices had been randomly allotted.

Intervention: All members acquired a bimonthly suggestions report. The intervention group moreover acquired potential monetary incentives on GP degree relying on their efficiency.

Fundamental measures: Between-group variations in proportions of sufferers fulfilling incentivized QM (course of QM of annual HbA1c measurement and scientific QM of blood strain degree beneath 140/95 mmHg) after 12 months.

Key outcomes: Seventy-one GPs (median age 52 years, 72% male) from 43 completely different practices and subsequently 3838 sufferers with diabetes mellitus (median age 70 years, 57% male) had been included. Proportions of sufferers with annual HbA1c measurements remained unchanged (intervention group decreased from 79.Zero to 78.3%, management group from 81.5 to 81.0%, OR 1.09, 95% CI 0.90-1.32, p = 0.39). Proportions of sufferers with blood strain beneath 140/95 improved from 49.9 to 52.5% within the intervention group and decreased from 51.2 to 49.0% within the management group (OR 1.16, 95% CI 0.99-1.36, p = 0.06). Proportions of non-incentivized course of QMs elevated considerably within the intervention group.

Conclusion: GP degree monetary incentives didn’t end in extra frequent HbA1c measurements or in improved blood strain management. Curiously, we might verify a spill-over impact on non-incentivized course of QMs. But, the mechanism of spill-over results of monetary incentives is essentially unclear.

 

Glycemic outcomes associated to melancholy in adults with kind 1 diabetes

Glycemic outcomes of adults with kind 1 diabetes could also be affected by melancholy. Our goal was to match outcomes of “depressed” (Affected person Well being Questionnaire-9 ⩾ 10, N = 83) to “not-depressed” matched management (Affected person Well being Questionnaire-2 < 3, N = 166) adults with kind 1 diabetes with goal measures.

The depressed group had poorer blood glucose management and, for these with glucose meter downloads, fewer glucose assessments/day. The teams didn’t differ on glucose variability or episodes of hypoglycemia. Despair in adults with kind 1 diabetes is related to poorer glycemic management and fewer blood glucose monitoring. Future analysis ought to study whether or not remedy of melancholy ends in higher self-care and glycemic outcomes.

 

, , , , , ,

Post navigation

Leave a Reply

Your email address will not be published. Required fields are marked *